 |
| Kodak enters the field of medicine with American investments |
Kodak was once a pioneer in the manufacture of images and entered the pharmaceutical and pharmaceutical industries. The U.S. government plans to give the company a $ 765 million loan to support its efforts.
Kodak will create a new business unit (Kodak Pharmaceuticals) to manufacture components needed to manufacture medicines.
Kodak Pharmaceuticals is expected to produce raw materials for chronic ethnic deficiency.
The U.S. loan is designed to help manufacture drugs nationwide that can treat various diseases and reduce the United States' dependence on foreign sources like China and India.
Kodak estimates that once the section is fully functional, Kodak can produce up to 25% of the active pharmaceutical ingredients used in non-biological and generic drugs.
According to the Wall Street Journal report, CEO of Kodak Jim Continenza (Jim Continenza) predicts that drugs will make up 30-40% of Kodak's business.
"We have a long history of more than 100 years in chemicals and advanced materials," Cantanza said, adding that Kodak's current infrastructure allows it to get started quickly.
The $ 765 million loan was awarded under the Korean War Defense Production Act, previously used by the Trump administration. Speed up the production of ventilation masks, masks and other medical devices to combat (COVID-19).
According to the Wall Street Journal, the director of photography sales is planning to manufacture pharmaceutical ingredients like anti-malarial hydroxychloroquine as part of his pharmaceutical work.
President Trump often promotes chloroquine to treat the areola virus, but facts have shown that the drug is frequently ineffective against the virus.
Anthony Fossey, director of the National Institute of Allergy and Infectious Diseases, said: Ongoing clinical studies on the effectiveness of chloroquine show that it is ineffective against coronaviruses.
It should be noted that although Kodak was with the company only a few years ago, it is not the first attempt to enter the drug trade.
Kodak acquired the drug manufacturer Sterling Drug in 1988 for about $ 5.1 billion and sold it in installments in 1994.
The company, based in Rochester, New York, was a pioneer at the time with 145,000 employees worldwide and invented the digital camera in 1975, but it did not use it.